Literature DB >> 3691602

Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.

S Loft1, K Simonsen, T Evald, H R Christensen, J Sonne, M Døssing.   

Abstract

The influence of prednisolone on the elimination of antipyrine has been investigated. The one-sample antipyrine clearance was estimated in 23 outpatients with obstructive lung disease before and after treatment with prednisolone 30 or 50 mg/day for 7 days. During prednisolone administration antipyrine clearance decreased from 54.9 +/- 14.8 to 51.7 +/- 14.6 ml/min (mean +/- SD; p less than 0.05). The results indicate that prednisolone decreases the rate of antipyrine elimination, but not to an extent suggesting a clinically important change in hepatic drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691602     DOI: 10.1007/bf00610387

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.

Authors:  A Breckenridge; C W Burke; D S Davies; M L Orme
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

3.  High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.

Authors:  G Klintmalm; J Säwe
Journal:  Lancet       Date:  1984-03-31       Impact factor: 79.321

4.  Influence of corticosteroid on hexobarbital and tolbutamide disposition.

Authors:  D D Breimer; W Zilly; E Richter
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

5.  A one-sample method for antipyrine clearance determination in rats.

Authors:  H Pilsgaard; H E Poulsen
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

6.  Effects on hepatic microsomal N- and C-oxygenation of aromatic amines by in vivo corticosteroid or aminofluorene treatment, diet, or stress.

Authors:  E Arrhenius
Journal:  Cancer Res       Date:  1968-02       Impact factor: 12.701

7.  Pulmonary disease and antipyrine clearance.

Authors:  C Laybourn; P Tønnesen; S Loft; J Sonne; M Døssing
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

8.  The effect of corticosteroids on theophylline metabolism.

Authors:  D C Leavengood; A L Bunker-Soler; H S Nelson
Journal:  Ann Allergy       Date:  1983-04

9.  Influence of prednisolone on antipyrine and chloramphenicol disposition in rabbits.

Authors:  V K Shukla; S K Garg; V S Mathur
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

10.  Metabolism of phenazone in man after hydrocortisone administration.

Authors:  J Elfström; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.